Biopharmaceuticals

Products Biopharmaceuticals

Protagen AG: Your reliable partner for biotherapeutical development

UNIchip® allows faster and more efficient selection of monoclonal antibodies and high affinity biotherapeutic reagents with improved specifity and stability in the development phase. more

News Biopharmaceuticals

• Big Pharma Embraces Biologics

  Fast-evolving biopharmaceuticals will challenge synthetic market dominance in the global market for active pharmaceutical ingredients (APIs), states a new report by business intelligence providers GBI Research.The new report "Active Pharmaceutical Ingredients (APIs) Global Market to 2017 - Growth in more

• PolyTherics expands collaboration with a top five pharmaceutical company

  PolyTherics Limited, a provider of solutions to enable the development of better biopharmaceuticals, has extended its collaboration with a top five pharmaceutical company to further investigate applications of PolyTherics’ polymer, PolyPEG®. PolyPEG™ is a patented polymer designed to extend the half more

• GE Healthcare Life Sciences completes acquisition of Xcellerex, Inc.

  GE Healthcare announced that it has completed the acquisition of Xcellerex, Inc., a supplier of manufacturing technologies for the fast-growing biopharmaceutical industry. The acquisition expands GE Healthcare’s offering of technologies and services for the manufacture of biopharmaceuticals such as more

White papers Biopharmaceuticals

• Characterizing Biotherapeutics with HPLC
  

  As demonstrated here, there are a broad range of HPLC applications used in development, production, validation and release of protein therapeutics for human use. Some of the applications mentioned above are mandatory when submitting a new biopharmaceutical to approval at the regulatory agencies. The introduction of the first so-called biosimilars in Europe further increased the demand for highly efficient analysis methods. The continuous development of new stationary phases for the common modes of biochromatography, such as size exclusion, ion exchange and hydrophilic interaction chromatography support biochemists in increasing lab productivity and establishing high-throughput HPLC analysis not only for small molecules but also for large biopolymers more

Publications Biopharmaceuticals

• Microneedles for intradermal and transdermal drug delivery

  Publication date: Available online 13 May 2013 Source:European Journal of Pharmaceutical Sciences Author(s): Tuan-Mazlelaa Tuan-Mahmood , Maelíosa T.C. McCrudden , Barbara M. Torrisi , Emma McAlister , Martin J. Garland , Thakur Raghu Raj Singh , Ryan F. Donnelly The formidable barrier more

• Process analytical technology (PAT) tools for the cultivation step in biopharmaceutical production

  The process analytical technology (PAT) initiative is now 10 years old. This has resulted in the development of many tools and software packages dedicated to PAT application on pharmaceutical processes. However, most applications are restricted to small molecule drugs, mainly for the relatively si more

• Micro–flow imaging and resonant mass measurement (archimedes) – complementary methods to quantitatively differentiate protein particles and silicone oil droplets

  Abstract Our study aimed to comparatively evaluate Micro–Flow Imaging (MFI) and the recently introduced technique of resonant mass measurement (Archimedes, RMM) as orthogonal methods for the quantitative differentiation of silicone oil droplets and protein particles. This distinction in the subm more

Market studies Biopharmaceuticals

• iBio, Inc. (NYSE ) - Financial and Strategic SWOT Analysis Review

  iBio, Inc. (iBio, formerly iBioPharma, Inc.) is a biotechnology company, engaged in the development of vaccines and therapeutic proteins based on its plant-based iBioLaunch platform technology, which is used in the manufacture of biopharmaceuticals. Its products include influenza vaccines, biodefenc more

• D-Pharm Ltd. - Strategic SWOT Analysis Review

  D-Pharm LTD.(D-Pharm) is a specialty bio-pharmaceutical company. It is engaged in the design and development of innovative drugs for the treatment of the brain disorders. It has developed two unique platform technologies that generate lipid–like medicines which utilizes lipid specific mechanisms and more

• Global Biopharmaceuticals Market 2011-2015

  TechNavio's analysts forecast the Global Biopharmaceuticals market to grow at a CAGR of 4.9 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increased adoption of advanced technologies. The Global Biopharmaceuticals market has also been witnessing t more

Websites Biopharmaceuticals